Background: Although high soy consumption may be associated with lower breast cancer risk in Asian populations, findings from epidemiological studies have been inconsistent. Objective: We investigated the effects of soy intake on breast cancer risk among Korean women according to their menopausal and hormone receptor status. Methods: We conducted a case-control study with 358 incident breast cancer patients and 360 age-matched controls with no history of malignant neoplasm. Dietary consumption of soy products was examined using a 103-item food frequency questionnaire. Results: The estimated mean intakes of total soy and isoflavones from this study population were 76.5 g per day and 15.0 mg per day, respectively. Using a multivariate logistic regression model, we found a significant inverse association between soy intake and breast cancer risk, with a dose-response relationship (odds ratios (OR) (95% confidence interval (CI)) for the highest vs the lowest intake quartile: 0.36 (0.20-0.64)). When the data were stratified by menopausal status, the protective effect was observed only among postmenopausal women (OR (95% CI) for the highest vs the lowest intake quartile: 0.08 (0.03-0.22)). The association between soy and breast cancer risk did not differ according to estrogen receptor (ER)/progesterone receptor (PR) status, but the estimated intake of soy isoflavones showed an inverse association only among postmenopausal women with ER þ /PR þ tumors. Conclusions: Our findings suggest that high consumption of soy might be related to lower risk of breast cancer and that the effect of soy intake could vary depending on several factors.
Our data show that the severity of emphysema, severe static hyperinflation and serum lower protein levels are independent predictors of frequent exacerbations in COPD patients.
37Acetaminophen (APAP) overdose is a leading cause of untreatable liver failure. In the mouse 38 model of APAP-induced liver injury (AILI), the administration of recombinant human 39 interleukin 11 (rhIL11) is protective. Here we show that the beneficial effect of rhIL11 in the 40 mouse is due to its unexpected and paradoxical inhibition of endogenous mouse IL11 activity. 41 Contrary to the accepted paradigm IL11 is a potent hepatotoxin across species, which is secreted 42 from damaged hepatocytes to drive an autocrine loop of NOX4 and JNK-dependent apoptosis. 43Mice with hepatocyte-specific Il11 expression spontaneously develop liver failure whereas those 44 with Il11ra1 deletion are remarkably protected from AILI. Neutralizing anti-IL11R antibodies 45 administered to moribund mice 10 hours following a lethal APAP overdose results in 90% 46 survival that is associated with very large liver regeneration. Our data overturn a misconception, 47 identify a new disease mechanism and suggest IL11 as a therapeutic target for liver regeneration. 49Main text 50 Acetaminophen (N-acetyl-p-aminophenol, APAP) is an over-the-counter analgesic that is 51 commonly taken as an overdose (OD) leading to APAP-induced liver injury (AILI), a major 52 cause of acute liver failure 1 . The antioxidant N-acetyl cysteine (NAC) is beneficial for patients 53 presenting early 2 , but there is no drug-based treatment beyond eight hours post-OD and death 54 can ensue if liver transplantation is not possible 3,4 . 55In hepatocytes, APAP is metabolized to N-Acetyl-p-benzochinonimin (NAPQI) which 56 depletes cellular glutathione (GSH) levels and damages mitochondrial proteins leading to 57 reactive oxygen species (ROS) production and JNK activation 5 . ROS-related JNK activation 58 results in a combination of necrotic, apoptotic and other forms of hepatocyte cell death causing 59 liver failure 1,6,7 . JNK and ASK1 inhibitors have partial protective effects against AILI in mouse 60 models, but this has not translated to the clinic 8,9 . 61Liver regeneration has fascinated humans since the stories of Prometheus and can be 62 truly profound, as seen after partial hepatic resection in rodents and humans 10,11 . However, in the 63 setting of AILI, liver regeneration is persistently suppressed resulting in permanent injury and 64 patient mortality. Targeting the pathways that hinder the liver's extraordinary regenerative 65 capacity may trigger natural regeneration, which could be particularly useful in AILI 12,13 . 66Interleukin 11 (IL11) is a scarcely studied cytokine that is of critical importance for 67 myofibroblast activation and fibrosis of the heart, kidney, lung, and liver [14][15][16] . It is established 68 that IL11 is secreted from injured hepatocytes and Il11 can be detected at high levels in the 69 serum of the mouse model of AILI, where its expression is considered compensatory and 70 cytoprotective 17 . In keeping with this paradigm, administration of recombinant human IL11 71 (rhIL11) is effective in treating the mouse model of A...
Paradoxical response developed in 16% of the patients approximately 2 months after initiation of anti-tuberculosis treatment, presenting with aggravation of pre-existing pleural effusion. Development of paradoxical response was associated with the proportion of eosinophils and protein concentrations in the pleural fluid at the time of diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.